Skip Navigation

Phase I Clinical Trial of CA-4948 Emavusertib in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT06696768

Study #:
STUDY00161818

Start Date:
Sep 05, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06696768

View Complete Trial Details & Eligibility at ClinicalTrials.gov